Aurora sponsors cancer-pain study featuring MedReleaf capsules. Continue reading Aurora Cannabis sponsors cancer-pain study directed by internationally acclaimed oncologist.
Approximately 60 patients suffering breakthrough cancer pain to participate in clinical trial that compares fentanyl with inhaled medical cannabis. Continue reading UPDATED: Cannabis vs. fentanyl for cancer pain; clinical trial
Canaccord Genuity Growth Corp. complete reverse merger Continue reading Columbia Care and Canaccord Genuity Growth Corp. merger in Q1
Over the past half century or more, scientists and medical researchers have made hundreds of thousands of important discoveries about cannabis and its potential as medicine. Continue reading “OLD” CANNABIS RESEARCH FINALLY SEES THE LIGHT OF DAY. IT’S ABOUT TIME.
Approximately 136 US military veterans in the San Diego area will participate in a phase 2 clinical trial that will test the effects of CBD on Post-Traumatic-Stress Disorder. Continue reading Clinical trial: CBD for veterans with PTSD
CannTrust investing approx. CAD $6 million for 20% stake in Australian company Cannatrek. Continue reading CannTrust stakes claim in Australia
Inhaling cannabis makes for easier breathing, because it dilates – or opens up – the airways in the lungs, according to a 1973 study published in New England Journal of Medicine.
Continue reading BREATHING EASIER: SCIENTISTS DISCOVERED 46 YEARS AGO THAT INHALING CANNABIS OPENED UP AIRWAYS IN THE LUNGS
GW Pharmaceuticals’ research and development for the therapeutic use of cannabinoids dates back at least two decades.
Continue reading Patents granted to GW Pharmaceuticals for therapeutic use of cannabinoids
Aphria’s Australian-based partner Althea granted Manufacture Licence by the Australian Government’s Office of Drug Control.
Health Canada approval for next phase of vaporized cannabinoid drug clinical trial.
Clinical trial to start and finish by year end Continue reading Health Canada approves next phase of clinical trial to study Tetra Bio-Pharma’s vaporized cannabis drug